Fig. 4From: Association of CYP24A1 with survival and drug resistance in clinical cancer patients: a meta-analysisForest plots of studies evaluating the association between CYP24A1 to prognosis by treatment subgroup analysis. CI, confidence interval; HR, Hazard ratioBack to article page